Drug search by name

Bevacizumab-awwb and Bleeding

Result of checking the interaction of drug Bevacizumab-awwb and disease Bleeding for safety when used together.

Check result:

Bevacizumab-awwb <> Bleeding

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Bevacizumab impairs wound healing and increases the occurrence of wound-related complications, which might require surgical intervention. Bevacizumab should not be started for at least 28 days after surgery and until the wound is fully healed. Discontinue bevacizumab in patients with wound healing complications requiring medical intervention or in patients who develop necrotizing fasciitis. Do not administer this agent to patients with recent history of hemoptysis and discontinue bevacizumab in patients with hemorrhage. Caution is recommended when using this agent in patients at increased risk of bleeding or before surgery and is recommended to stop therapy for at least 28 days prior to elective surgery.

Bevacizumab-awwb

Generic Name: bevacizumab

Brand Name: Avastin, Mvasi

Synonyms: Bevacizumab

What is Bevacizumab-awwb?